Showing 81-90 of 3101 results for "".
Vitamin D: Considerations for Treatment, Prevention, and Risk in Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/vitamin-d-considerations-for-treatment-prevention-and-risk-in-multiple-sclerosis-care/30373/Preliminary signals are strong that vitamin D has a role to play in MS, but more research is needed to confirm the need for supplementation as a preventive or therapeutic measure.The Importance of Early Diagnosis and Treatment of Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-importance-of-early-diagnosis-and-treatment-of-alzheimer-disease/35436/Linda Shows, a semi-retired nurse who lives with mild cognitive impairment, and her physician, Wendell Helveston, MD, Hattiesburg Clinic, Hattiesburg, MS, discuss the importance of early diagnosis and treatment in Alzheimer disease, including other factors that can help patients thrive when living wThe Use of Intracranial Vessel Wall MRI for the Diagnosis of Vasculitis
https://practicalneurology.com/diseases-diagnoses/stroke/the-use-of-intracranial-vessel-wall-mri-for-the-diagnosis-of-vasculitis/37234/Jae W. Song, MD, MS, Associate Professor of Radiology at the University of Pennsylvania, Philadelphia, PA, discusses the diagnostic value of intracranial vessel wall MRI for vasculitis, as well as when clinicians should order this imaging technique and the challenges that may arise.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31238/Differentiating Multiple Sclerosis (MS) from Sjögren’s Syndrome (SS) is critical due to overlapping neurological manifestations and distinct treatment pathways. A clinical case of a 49-year-old woman presenting with ataxia and band-like paresthesias initially suggests MS, supported by MRI findings o
Generalized Myasthenia Gravis: Inside the MINT Trial and CD19 B-Cell Therapy Advances
https://practicalneurology.com/diseases-diagnoses/neuromuscular/generalized-myasthenia-gravis-inside-the-mint-trial-and-cd19-b-cell-therapy-advances/57164/Richard J. Nowak, MD, MS, Associate Professor of Neurology, Yale School of Medicine, Yale University, New Haven, CT and global principal investigator of the Myasthenia Gravis Inebilizumab Trial (MINT), discusses the phase 3 results, highlighting the safety and efficacy of CD19-targeted B-cell therap- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31137/Clinical Insights: Recent Advances in NeurologyRecent genetic studies continue to illuminate the complex interplay between genetics and multiple sclerosis (MS). A genome-wide association study published in the *New England Journal of Medicine* identified heritable risk factors for MS, specifically a
Men With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/men-with-multiple-sclerosis/31758/Men with MS comprise an unlikely minority with distinct challenges that may also intersect with other signifiers of special populations.Maturing with Migraine: Practical Guidelines for Transitioning Adolescent Migraine and Headache Patients into Adult Practice
https://practicalneurology.com/diseases-diagnoses/headache-pain/maturing-with-migraine-practical-guidelines-for-transitioning-adolescent-migraine-and-headache-patients-into-adult-practice/48903/Hope O’Brien, MD, MBA, FAHS, FAAN, Founder and CEO of the Headache Center of Hope, Cincinnati, OH, discusses challenges and considerations for adult headache neurologists who are onboarding adolescent patients as they transition from pediatric practice. Dr. O’Brien highlights a framework with strateMultiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.Multiple Sclerosis in the Hispanic/Latinx Population
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-hispaniclatinx-population/31757/Hispanic/Latinx individuals with MS are a diverse group for whom genetic and environmental factors affect prevalence, disease course, and treatment that varies by region.